KBC Group
ORKA icon

KBC Group’s Oruka Therapeutics ORKA Stock Holding History

KBC Group’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$103K Buy
+1,234
New +$116K ﹤0.01% 1365

Other funds holding ORKA

Secure Asset Management
Secure Asset Management Troy, Michigan $753M AUM 20.9% 1-Year Est. Return
First Affirmative Financial Network
First Affirmative Financial Network Colorado Springs, Colorado $456M AUM
PR
PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Activest Wealth Management
Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return
Versant Capital Management
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

KBC Group's ORKA Position: Q3 2026 in Review

KBC Group opened a new position in Oruka Therapeutics (ORKA) in Q3 2026: 1,234 shares worth $103K. The stake represents ﹤0.01% of the portfolio and ranks #1365 among its holdings.

18 funds tracked by Wall St. Rank hold ORKA as of Q3 2026.

  • KBC Group held 1,234 shares of Oruka Therapeutics worth $103K as of Q3 2026.
  • Oruka Therapeutics was a new KBC Group position in Q3 2026.
  • Oruka Therapeutics made up ﹤0.01% of KBC Group's portfolio in Q3 2026, its #1365 holding.
  • 18 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2026.

Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.